Pharmacy chain BENU is warning that a steep price increase for the blood thinner Eliquis is threatening patient access to ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

BMY gears up for Q2 results as growth drugs partially offset legacy declines, cost cuts kick in and new launches gain ...

Here are four high-yield blue-chip pharmaceutical stocks positioned to outperform and offer huge total return potential.